Apparent extinction of non-G2 rotavirus strains from circulation in Recife, Brazil, after the introduction of rotavirus vaccine

Archives of Virology

Volumn 153, Issue 3, 2008, Pages 591-593

  Nakagomi, T ^a,b   Cuevas, L E ^c   Gurgel, R G ^c,d   Elrokhsi, S H ^c   Belkhir, Y A ^c   Abugalia, M ^c   Dove, W ^b   Montenegro, F M U ^e   Correia, J B ^e   Nakagomi, O ^a,b   Cunliffe, N A ^b   Hart, C A ^b  

^a NAGASAKI UNIVERSITY   (Japan)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^d FEDERAL UNIVERSITY OF SERGIPE   (Brazil)

^e INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

LIVE VACCINE; ROTAVIRUS VACCINE;

ARTICLE; BRAZIL; CLASSIFICATION; GASTROENTERITIS; HUMAN; IMMUNOLOGY; INFANT; INFANTILE DIARRHEA; ISOLATION AND PURIFICATION; PRESCHOOL CHILD; PREVENTIVE HEALTH SERVICE; ROTAVIRUS; VIROLOGY; VIRUS INFECTION;

BRAZIL; CHILD, PRESCHOOL; DIARRHEA, INFANTILE; GASTROENTERITIS; HUMANS; IMMUNIZATION PROGRAMS; INFANT; ROTAVIRUS; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; VACCINES, ATTENUATED;

ROTAVIRUS;

EID: 39749111305     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00705-007-0028-z     Document Type: Article

References (14)

1. Araujo IT, Fialho AM, de Assis RM, M, Galvao M, Cruz CM, Ferreira MS, Leite JP (2002) Rotavirus strain diversity in Rio de Janeiro, Brazil: characterization of VP4 and VP7 genotypes in hospitalized children. J Trop Pediatr 48:214-218
2. Bok K, Castagnaro N, Borsa A, Nates S, Espul C, Fay O, Fabri A, Grinstein S, Miceli I, Matson DO, Gomez JA (2001) Surveillance for rotavirus in Argentina. J Med Virol 65:190-198
3. Castello A, Arvay M, Glass R, Gentsch J (2004) Rotavirus strain surveillance in Latin America: a review of the last nine years. Pediatr Infect Dis J 23(suppl):168-172
4. Cunliffe NA, Nakagomi O (2005) A critical time for rotavirus vaccines: a review. Expert Rev Vaccines 4:521-532
5. Estes MK, Kapikian AZ (2007) Rotavirus. In: Knipe DM, Howley PM (eds) Fields virology. 5th edn. vol 2. Lippincott Williams and Wilkins, Philadelphia, pp 1917-1974
6. Gentsch JR, Glass RI, Woods P, Gouvea V, Gorziglia M, Flores J, Das BK, Bhan MK (1992) Identification of group A rotavirus gene 4 types by polymerase chain reaction. J Clin Microbiol 30:1365-1373
7. Gouvea V, Glass RI, Woods P, Taniguchi K, Clark HF, Forreter B, Fang ZY (1990) Polymerase chain reaction amplification and typing of rotavirus nucleic acids from stool specimens. J Clin Microbiol 28:276-282
8. Kapikian AZ, Hoshino Y (2007) To serotype or not to serotype: that is still the question. J Infect Dis 195:625-632
9. Kutsuzawa T, Konno T, Suzuki H, Kapikian AZ, Ebina T, Ishida N (1982) Isolation of human rotavirus subgroups 1 and 2 in cell culture. J Clin Microbiol 16:727-730
10. Montenegro FM, Correia JB, Falbo AR, Dove W, Nakagomi T, Nakagomi O, Cuevas LE, Cunliffe NA, Hart CA (2007) Anticipating rotavirus vaccines in Brazil: detection and molecular characterization of emerging rotavirus serotypes G8 and G9 among children with diarrhea in Recife, Brazil. J Med Virol 79:335-340
11. Parashar UE, Gibson CJ, Bresee J, Glass R (2006) Rotavirus and severe childhood diarrhea. Emerg Infect Dis 12:304-306
12. PATH's Rotavirus Vaccine Program (2006) Accelerating the introduction of rotavirus vaccines into GAVI-eligible countries. http://www.gavialliance.org/ resources/Rotavirus_Investment_Case_Oct06.pdf. Accessed 10 Oct 2007
13. Ruiz-Palacios GM, Perez-Schael I, Velazquez FR, Abate H, Breuer T, Clemens SC, Cheuvart B, Espinoza F, Gillard P, Innis BL, Cervantes Y, Linhares AC, Lopez P, Macias-Parra M, Ortega-Barria E, Richardson V, Rivera-Medina DM, Rivera L, Salinas B, Pavia-Ruz N, Salmeron J, Ruttimann R, Tinoco JC, Rubio P, Nunez E, Guerrero ML, Yarzabal JP, Damaso S, Tornieporth N, Saez-Llorens X, Vergara RF, Vesikari T, Bouckenooghe A, Clemens R, De Vos B, O'Ryan M; Human Rotavirus Vaccine Study Group (2006) Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 354:11-22
14. Vesikari T, Matson DO, Dennehy P, Van Damme P, Santosham M, Rodriguez Z, Dallas MJ, Heyse JF, Goveia MG, Black SB, Shinefield HR, Christie CD, Ylitalo S, Itzler RF, Coia ML, Onorato MT, Adeyi BA, Marshall GS, Gothefors L, Campens D, Karvonen A, Watt JP, O'Brien KL, DiNubile MJ, Clark HF, Boslego JW, Offit PA, Heaton PM; Rotavirus Efficacy, Safety Trial (REST) Study Team (2006) Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 354:23-33